L Shah1, H W Choi2, L Berrang-Ford3, G Henostroza4, F Krapp5, C Zamudio5, S J Heymann6, J S Kaufman1, A Ciampi1, C Seas5, E Gotuzzo5, T F Brewer7. 1. Department of Epidemiology, Biostatistics & Occupational Health, McGill University, Montreal, Quebec, Canada. 2. Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. 3. Department of Geography, McGill University, Montreal, Quebec, Canada. 4. Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA. 5. Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru. 6. Department of Epidemiology, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, USA. 7. Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
Abstract
SETTING: Peru reports among the highest multidrug-resistant tuberculosis (MDR-TB) rates in the Americas, with a growing proportion in previously untreated tuberculosis (TB) cases. The identification of clusters of primary MDR-TB compared with drug-susceptible TB (DS-TB) could help prioritize interventions. OBJECTIVE: To examine the clustering of primary MDR-TB case residences and their proximity to high-risk locations in San Juan de Lurigancho District, Lima, Peru. DESIGN: Enrolled primary MDR-TB and primary DS-TB cases were interviewed and their primary residence was recorded using handheld Global Positioning System devices. Kuldorff's spatial scan statistic was used for cluster detection (SaTScan(TM), v. 9.1.1). Identified clusters were visualized in Quantum Geographic Information Systems software (v1.8.0). The following cluster centers were tested: a health centre with the highest TB and MDR-TB rates (Clinic X), a hospital and two prisons. Using regression analyses, we examined predictors of primary MDR-TB cases. RESULTS: A statistically significant cluster of primary MDR-TB cases was identified within a 2.29 km radius around Clinic X. Proximity to Clinic X remained a significant predictor of primary MDR-TB in adjusted regression analyses. CONCLUSION: We identified a hotspot of primary MDR-TB cases around Clinic X in a TB-endemic area. Causes of this clustering require investigation; targeted interventions for this high-risk area should be considered.
SETTING: Peru reports among the highest multidrug-resistant tuberculosis (MDR-TB) rates in the Americas, with a growing proportion in previously untreated tuberculosis (TB) cases. The identification of clusters of primary MDR-TB compared with drug-susceptible TB (DS-TB) could help prioritize interventions. OBJECTIVE: To examine the clustering of primary MDR-TB case residences and their proximity to high-risk locations in San Juan de Lurigancho District, Lima, Peru. DESIGN: Enrolled primary MDR-TB and primary DS-TB cases were interviewed and their primary residence was recorded using handheld Global Positioning System devices. Kuldorff's spatial scan statistic was used for cluster detection (SaTScan(TM), v. 9.1.1). Identified clusters were visualized in Quantum Geographic Information Systems software (v1.8.0). The following cluster centers were tested: a health centre with the highest TB and MDR-TB rates (Clinic X), a hospital and two prisons. Using regression analyses, we examined predictors of primary MDR-TB cases. RESULTS: A statistically significant cluster of primary MDR-TB cases was identified within a 2.29 km radius around Clinic X. Proximity to Clinic X remained a significant predictor of primary MDR-TB in adjusted regression analyses. CONCLUSION: We identified a hotspot of primary MDR-TB cases around Clinic X in a TB-endemic area. Causes of this clustering require investigation; targeted interventions for this high-risk area should be considered.
Authors: Jonathan L Zelner; Megan B Murray; Mercedes C Becerra; Jerome Galea; Leonid Lecca; Roger Calderon; Rosa Yataco; Carmen Contreras; Zibiao Zhang; Justin Manjourides; Bryan T Grenfell; Ted Cohen Journal: J Infect Dis Date: 2015-07-14 Impact factor: 5.226
Authors: David P Bui; Eyal Oren; Denise J Roe; Heidi E Brown; Robin B Harris; Gwenan M Knight; Robert H Gilman; Louis Grandjean Journal: Clin Infect Dis Date: 2019-04-24 Impact factor: 9.079
Authors: Mary Claire Worrell; Michael Kramer; Aliya Yamin; Susan M Ray; Neela D Goswami Journal: Open Forum Infect Dis Date: 2017-01-09 Impact factor: 3.835
Authors: Marie Brunetti; Sathyanath Rajasekharan; Piluca Ustero; Katherine Ngo; Welile Sikhondze; Buli Mzileni; Anna Mandalakas; Alexander W Kay Journal: Glob Health Res Policy Date: 2018-02-05
Authors: Joshua L Warren; Louis Grandjean; David A J Moore; Anna Lithgow; Jorge Coronel; Patricia Sheen; Jonathan L Zelner; Jason R Andrews; Ted Cohen Journal: BMC Med Date: 2018-08-03 Impact factor: 8.775
Authors: Debebe Shaweno; Malancha Karmakar; Kefyalew Addis Alene; Romain Ragonnet; Archie Ca Clements; James M Trauer; Justin T Denholm; Emma S McBryde Journal: BMC Med Date: 2018-10-18 Impact factor: 8.775